Introduction
Studies show that cancer is most deadly disease in the world due to the uncontrolled growth and spread of abnormal cells anywhere in a body [1] .In spite of all the efforts made so far, cancer is difficult to cure. The main reason for this difficulty is that cancer results from the uncontrolled multiplication of subtly modified normal human cells.
Most of the drugs used for the treatment of cancer are cytotoxic (cell-killing) drugs that work by interfering in some way with the operation of the cell's DNA. Unfortunately cytotoxic drugs have the potential to be very harmful to the body unless they are very specific to cancer cells which is difficult to achieve. Therefore a major challenge is to design new drugs that will be more selective for cancer cells, with lesser side effects.
Several studies have shown the effect of bisophosphonates on cancer cells and it is an established fact that their anti-tumor activity is related to interference with mevalonate pathway [2] . Bisphosphonate compounds are widely used since 1970 for disorders of bone metabolism like paget's disease and osteoporosis [3] . Researchers in this field have shown that nitrogen containing bisphosphonates are extensively used to block bone destruction in cancer patients with bone metastasis. They are effective inhibitors of osteoclast-mediated bone resorption. It has also been observed that nitrogen containing bisphosphonates have anti cancer activities through inhibition of tumor cell functions, enhancement of the cytotoxic activity of chemotherapy agents, inhibition of tumor angiogenesis and stimulation of antitumor immune reactions.
II. Methodology Used
The methodology used in the present study is to model the anti-cancer activities of bis phosphonates using topological indices. Quantitative Structure Activity Relationship (QSAR) modeling establishes a quantitative correlation between chemical structure and biological activity [4] . In the present study we took 24 compounds with log1/IC 50 activities reported in the literature [5] . In this work the biological activity of molecules has been taken as log1/IC 50 which is negative log of IC 50 values and is known as the concentration of test compound required to inhibit 50% activity. The structural details of bisphosphonate compounds which act as anticancer compounds are given in Table 1 .DRAGON software [6] has been used for calculation of topological descriptors. These calculated descriptors are reported in Table 2 In fact topological parameters have been very successfully used by us in modeling different activities of drug molecules [7] [8] [9] [10] .From the descriptors calculated useful descriptors were generated by variable selection of descriptors in multiple regression analysis using NCSS software [11] .Finally the proposed models obtained were subjected to crossvalidation by leave-one-out procedure [12] .
III. Results And Discussions
The biological activities of these compounds in terms of log 1/IC 50 are reported in Table 2 . Table 2 also contains calculated parameters viz-Balaban and Balaban type indices and zero to three order valence-connectivity indices. The correlation matrix among all the topological indices and biological activity is reported in Table 3 . A close look at this table clearly indicates that for modeling log1/IC 50 activity connectivity indices play a dominant role. However, it is interesting to observe that higher order valence-connectivity indices show a decreasing trend. The 1 st and 2 nd order connectivity-indices show good correlation. The data was subjected to regression analysis and the best obtained correlations are summarized in Table 4 . On the basis of R 2 following models are best for modeling the anticancer activity of these compounds:
One variable model (model no. 4, Table 4 st order valence-connectivity index for which the R 2 value comes to be 0.8513. The systematic addition of topological indices gave three bi-parametric correlations which were found statistically better than the mono-parametric correlations. However the best bi-parametric model among these contains 1 χ v and J hetp. The R 2 value for this bi-parametric model comes out to be 0.8863. The adjusted R 2 for this model is 0.8749, which clearly indicates that addition of J hetp is justified .Further improvement in R 2 is observed when 3 χ v is added to the bi-parametric model the R 2 changes from 0.8863 to 0.9052. The R 2 A also show significant improvement from 0.8749 to 0.8903. On the basis of Pogliani's quality factor [13] [14] we infer that the threeparametric model is the best for modeling log 1/IC 50 activity of present set of compounds. Further confirmation is obtained by estimating the activity using model 16 which is reported in Table 5 . The estimated values are in good agreement with observed values. When observed activity values are plotted against estimated values, we obtained a graph which is reported in Fig. 1 . The predictive power of the model comes out to be 0.905.
Further confirmation is obtained by calculating cross-validated parameters from [8] [9] [10] [11] [12] [13] [14] [15] [16] . Such values are given in Table 6 . The PSE value close to0.4 for model 16 suggests that this model is the best. Also cross-validation R 2 value for model 16 comes to be 0.8953 which is the highest among all the discussed models. For any kind of possible defect we have calculated variance inflation factor, tolerance and condition number for various parameters using VIF plot which is given in Table 7 . All the parameters show the value within the permissible limit. Therefore the model is free from any kind of defect. Ridge trace suggests that there is no co-linearity in the model.
2.
1 χ v also shows negative coefficient 3.
3 χ v has a positive coefficient Since 3 χ v has a positive coefficient its higher value will give a improved value of log 1/IC 50 .The 1 st order branching is not favourable and similarly negative coefficient of Balaban type index J hetp suggest that the lower value of these parameters will enhance biological activity. While designing a new drug molecule these factors should be considered. 
